Injectable tirzepatide remains the most common form, but alternatives are entering the market
More recently, a randomized controlled trial in humans regarding the effects of a GLP-1 receptor agonist in people living with alcoholism suggested that it could be a new treatment for human addiction disorders (Klausen et al., 2022)
Both FSA and HSA cover compounded semaglutide, but FSAs are employer-sponsored with annual limits ($3,300 in 2024) and 'use-it-or-lose-it' rules, while HSAs are individual accounts tied to high-deductible health plans with higher limits ($4,150$8,300 in 2024) and unlimited rollover
Many people find that the reduced appetite leads to smaller meals, which can actually ease digestion
The growth hormone axis becomes dysregulated in many women with chronic pain conditions, including endometriosis
Plus, berberine is not an FDA-approved weight loss medication